For months Biden has touted his win over pharma in the election lead-up. Will it help?
Since at least mid-August, President Joe Biden has not been shy about how happy he is to have defeated Big Pharma with the passage of the Inflation Reduction Act and the subsequent Medicare drug price negotiations that will kick off in 2026.
Biden’s rallying cry around beating Big Pharma has been the highlight of stump speeches, even if he isn’t up for reelection, and even if he’s kept a relatively low profile in the lead-up to the midterms.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.